Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease (COVCALL)

Fondation Ophtalmologique Adolphe de Rothschild

Status: Completed

Conditions: Sjogren's Syndrome; Psoriatic Arthritis; SARS-CoV-2; Systemic Lupus Erythematosus; Rheumatoid Arthritis

Treatments: Other: Questionnaire by phone call

Study type: Observational

Funder types: NETWORK

Identifiers

NCT04345159

GDE_2020_11

Details and patient eligibility

About

This epidemiological, transversal, cohort study aims to determine the potential influence of an active long-term hydroxychloroquine intake over the prevalence of a history of symptoms evocative of a COVID-19 infection in patients with a history of systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome or psoriatic arthritis, during the epidemic period in France. The information is gathered using a standardized questionnaire, by phone call.

Enrollment: 572 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• History of Systemic Lupus Erythematosus, Rheumatoid arthritis, Sjogren's Syndrome or Psoriatic Arthritis.

Exclusion criteria

• beginning, or end, of an hydroxychloroquine treatment between Jan 1, 2020 and day of the phone call.
• Bad treatment compliance

Trial design

572 participants in 1 patient group

Patient with autoimmune disease

Description:

Selected using appropriate keywords in the Foundation Rothschild Hospital EMR, consenting to participate in the study.

Treatment:

Other: Questionnaire by phone call